BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1676911)

  • 1. DNA-RFLP methods and interpretation scheme for HLA-DR and DQ typing.
    Bidwell JL; Bignon JD
    Eur J Immunogenet; 1991; 18(1-2):5-22. PubMed ID: 1676911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of RFLP and PCR-ASO typing for HLA-DR-Dw and DQw typing.
    Bignon JD; Bidwell JL
    Eur J Immunogenet; 1991; 18(1-2):125-38. PubMed ID: 1676910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB and DQB typing by a combination of serology, restriction fragment length polymorphism analysis and oligonucleotide probing.
    Doherty DG; Donaldson PT
    Eur J Immunogenet; 1991; 18(1-2):111-24. PubMed ID: 1676909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonradioactive DNA/RFLP analysis for HLA DR and DQ allotypes.
    Crosby I; Beales P; Barnes RM
    Transplant Proc; 1992 Dec; 24(6):2481-2. PubMed ID: 1361259
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomic HLA-DR and -DQ typing by Taq I RFLP analysis: an alternative to serologic tissue typing.
    Olerup O; Zetterquist H; Ohlson L; Carlsson B; Wallin J; Möller E
    Transplant Proc; 1990 Feb; 22(1):144. PubMed ID: 1968689
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA-DR and DQ matching by DNA restriction fragment length polymorphism methods and the outcome of mixed lymphocyte reaction tests in unrelated bone marrow donor searches. The IMUST Study.
    Howard MR; Brookes P; Bidwell JL; Bidwell EA; Clay TM; Evans JL; Hows JM; Bradley BA
    Bone Marrow Transplant; 1992 Mar; 9(3):161-6. PubMed ID: 1354994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR and -DQ RFLP typing with digoxigenin-labelled DRB, DQA and DQB probes.
    Chen DF
    Tissue Antigens; 1993 Apr; 41(4):221-2. PubMed ID: 8103246
    [No Abstract]   [Full Text] [Related]  

  • 8. A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10.
    Bidwell JL; Bidwell EA; Savage DA; Middleton D; Klouda PT; Bradley BA
    Transplantation; 1988 Mar; 45(3):640-6. PubMed ID: 2894727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients.
    Noreen HJ; Davidson ML; McCullough J; Bach FH; Segall M
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2968-70. PubMed ID: 2468247
    [No Abstract]   [Full Text] [Related]  

  • 10. A simple and rapid method for HLA-DRB and -DQB typing by digestion of PCR-amplified DNA with allele specific restriction endonucleases.
    Uryu N; Maeda M; Ota M; Tsuji K; Inoko H
    Tissue Antigens; 1990 Jan; 35(1):20-31. PubMed ID: 1968291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction fragment length polymorphism (RFLP) heterogeneity of HLA-DQ beta genes associated with DNA fragment identical to the DR1-beta DNA structure.
    Redford A; Magalong D; Onohara-Toyoda M; Tyan D; Riley WJ; Maclaren NK; Rotter JI; Toyoda H
    Dis Markers; 1991; 9(5):257-63. PubMed ID: 1686750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-D typing of heterozygotes using restriction fragment length polymorphism in the HLA-DQ gene region on the basis of standard band patterns derived from HLA homozygotes.
    Maeda M; Inoko H; Ando A; Uryu N; Tsuji K
    Hum Immunol; 1989 Jul; 25(3):195-205. PubMed ID: 2570051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serological class II typing with DNA-DR and DNA-DQ typing of kidney donors and recipients.
    Trejaut J; Dunckley H; Sullivan JS; Doran T; Chapman J
    Transplant Proc; 1990 Oct; 22(5):2133. PubMed ID: 1977223
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogenotypes defined by short DQ alpha and DQ beta cDNA probes correlate with and define splits of HLA-DQ serological specificities.
    Bidwell JL; Bidwell EA; Laundy GJ; Klouda PT; Bradley BA
    Mol Immunol; 1987 May; 24(5):513-22. PubMed ID: 2889137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II DNA-RFLP typing in 102 individuals from Northern Greece.
    Adam K; Vavatsi N; Mytilineos J; Kouidou S; Polymenidis Z; Trakatellis A; Opelz G
    Transpl Int; 1994; 7 Suppl 1():S522-6. PubMed ID: 11271298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancies in serological tissue typing revealed by DNA techniques.
    Middleton D; Savage DA; Cullen C; Martin J
    Transpl Int; 1988 Oct; 1(3):161-4. PubMed ID: 2908097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR and DQ DNA genotyping in multiple sclerosis patients in Northern Ireland.
    Cullen CG; Middleton D; Savage DA; Hawkins S
    Hum Immunol; 1991 Jan; 30(1):1-6. PubMed ID: 1672121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II typing by digestion of PCR-amplified DNA with allele-specific restriction endonucleases will fail to unequivocally identify the genotypes of many homozygous and heterozygous individuals.
    Olerup O
    Tissue Antigens; 1990 Aug; 36(2):83-7. PubMed ID: 1980163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic HLA-typing by RFLP-analysis using DR beta and DQ beta cDNA probes reveals normal DR-DQ linkages in patients with multiple sclerosis.
    Olerup O; Carlsson B; Wallin J; Olsson T; Fredrikson S; Ernerudh J; Möller E
    Tissue Antigens; 1987 Sep; 30(3):135-8. PubMed ID: 2892282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRw11, DQw7 has four cellular subtypes revealed by homozygous typing cells and undetected by restriction fragment length polymorphism.
    Freidel AC; Gebuhrer L; Betuel H; Farre A; Labonne MP; Lambert J
    Hum Immunol; 1991 Mar; 30(3):183-9. PubMed ID: 1676026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.